دورية أكاديمية

Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects.

التفاصيل البيبلوغرافية
العنوان: Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects.
المؤلفون: McErlane KM; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Axelson J, Vaughan R, Kerr CR, Price JD, Igwemezie L, Pillai G
المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 1990; Vol. 39 (4), pp. 373-6.
نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print Cited Medium: Print ISSN: 0031-6970 (Print) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin, New York, Springer.
مواضيع طبية MeSH: Lidocaine/*analogs & derivatives , Uremia/*metabolism, Adult ; Female ; Half-Life ; Humans ; Lidocaine/blood ; Lidocaine/pharmacokinetics ; Male ; Metabolic Clearance Rate ; Stereoisomerism ; Tocainide ; Uremia/blood
مستخلص: The disposition of tocainide enantiomers were examined in healthy human subjects and uraemic patients following a single i.v. dose (200 mg) of racemic tocainide hydrochloride. In the healthy subjects, the total body clearance of R(-)-tocainide was significantly greater than that of S(+)-tocainide (2.62 vs 1.70 ml.min-1.kg-1). Renal clearance also favoured R(-)-tocainide and appeared to contribute significantly to the stereoselective total body clearance. The volume of distribution of the enantiomers did not differ significantly. Uraemia produced a marked decrease in the total body clearance with no apparent effect on the volume of distribution of both enantiomers. The S/R ratio for total body clearance decreased significantly from 0.66 in healthy subjects to 0.54 in the uraemics, while the ratio for terminal elimination half-life significantly increased from 1.43 to 1.59. These results indicate that uraemia alters the degree of stereoselectivity in the pharmacokinetic parameters of tocainide enantiomers.
References: Res Commun Chem Pathol Pharmacol. 1982 Oct;38(1):165-8. (PMID: 6815740)
Drugs. 1985 Oct;30(4):333-54. (PMID: 3905334)
Clin Pharmacokinet. 1981 Sep-Oct;6(5):329-45. (PMID: 7037261)
J Cardiovasc Pharmacol. 1988 Feb;11(2):235-41. (PMID: 2452320)
Biochem Pharmacol. 1988 Jan 1;37(1):9-18. (PMID: 3276322)
Med Res Rev. 1984 Jul-Sep;4(3):359-413. (PMID: 6087043)
J Med Chem. 1979 Oct;22(10):1171-6. (PMID: 513064)
Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. (PMID: 6362952)
Br J Clin Pharmacol. 1984 Jan;17(1):113-5. (PMID: 6419760)
Clin Pharmacol Ther. 1976 Jun;19(6):757-66. (PMID: 1269216)
J Chromatogr. 1983 May 13;274:129-38. (PMID: 6409913)
Clin Pharmacol Ther. 1986 Aug;40(2):125-33. (PMID: 3731675)
Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):215-22. (PMID: 6440790)
J Cardiovasc Pharmacol. 1988 Feb;11(2):216-21. (PMID: 2452317)
Circulation. 1976 Dec;54(6):885-9. (PMID: 791536)
Clin Pharmacol Ther. 1980 Jan;27(1):64-71. (PMID: 7351118)
Eur J Clin Pharmacol. 1983;24(4):503-7. (PMID: 6407848)
Br J Clin Pharmacol. 1986 Feb;21(2):149-54. (PMID: 3082345)
Drug Metab Dispos. 1982 Jul-Aug;10(4):399-404. (PMID: 6126341)
Res Commun Chem Pathol Pharmacol. 1984 Feb;43(2):209-21. (PMID: 6424192)
المشرفين على المادة: 27DXO59SAN (Tocainide)
98PI200987 (Lidocaine)
تواريخ الأحداث: Date Created: 19900101 Date Completed: 19910423 Latest Revision: 20190813
رمز التحديث: 20221208
DOI: 10.1007/BF00315413
PMID: 2127569
قاعدة البيانات: MEDLINE
الوصف
تدمد:0031-6970
DOI:10.1007/BF00315413